Compounds > 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione
Page last updated: 2024-09-02

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Carcinoma, Non-Small Cell Lung

3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, CH; Chen, MC; Liu, YN; Pan, SL; Teng, CM; Wang, HP1

Other Studies

1 other study(ies) available for 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione and Carcinoma, Non-Small Cell Lung

ArticleYear
TW01001, a novel piperazinedione compound, induces mitotic arrest and autophagy in non-small cell lung cancer A549 cells.
    Cancer letters, 2013, Aug-19, Volume: 336, Issue:2

    Topics: Autophagy; Benzoates; Carcinoma, Non-Small-Cell Lung; Cell Cycle Checkpoints; Cell Division; Cell Line, Tumor; Diketopiperazines; G2 Phase; Humans; Lung Neoplasms; Mitosis; Piperazines; Signal Transduction

2013